Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | MAPK10 | P53779 | 9/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 8/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 8/20 | 0.44 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.44 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10025574 | 0.81 | ALDH1A1 (0.46) | HSP90AA1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL2599158 | 0.79 | HSP90AA1 (1.00) | HSP90AA1MAPK10MAPK8MAPK9CSNK1D | |
| SCHEMBL7202159 | 0.77 | HSP90AA1 (0.79) | HSP90AA1MAPK10MAPK8MAPK9CSNK1D | |
| SCHEMBL7072802 | 0.76 | ALDH1A1 (0.56) | HSP90AA1MAPK10MAPK8MAPK9CSNK1D | |
| SCHEMBL9296347 | 0.75 | HSP90AA1 (0.57) | HSP90AA1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8179362 | 0.72 | HSP90AA1 (0.70) | HSP90AA1MAPK10MAPK8MAPK9GRIN2D | |
| SCHEMBL1275295 | 0.71 | ALDH1A1 (0.47) | HSP90AA1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL23912940 | 0.71 | HSP90AA1 (0.62) | HSP90AA1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL6407030 | 0.71 | HSP90AA1 (0.42) | HSP90AA1MAPK10MAPK8MAPK9CSNK1D | |
| SCHEMBL1275863 | 0.70 | HSP90AA1 (0.47) | HSP90AA1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767452-B2 | Curable composition, especially as crystallizing rubber to substrate bonding primer | HENKEL AG & CO. KGAA (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11767452-B2 | Curable composition, especially as crystallizing rubber to substrate bonding primer | HENKEL AG & CO. KGAA (DE) | 2023-09-26 | — | — | US | disclosed |
| EP-3369770-B1 | CURABLE COMPOSITION, ESPECIALLY AS CRYSTALLIZING RUBBER TO SUBSTRATE BONDING PRIMER | HENKEL AG & CO KGAA (DE) | 2021-12-22 | — | — | EP | disclosed |
| EP-2895546-B1 | IMPROVED BONDING COMPOSITION COMPRISING A SULFUR IMPREGNATED PARTICULATE SOLID | Henkel IP & Holding GmbH (DE) | 2020-06-10 | — | — | EP | disclosed |
| EP-2895544-B1 | IMPROVED BONDING COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2018-07-11 | — | — | EP | disclosed |
| US-20180163101-A1 | CURABLE COMPOSITION, ESPECIALLY FOR RUBBER TO SUBSTRATE BONDING | HENKEL AG & CO. KGAA (DE) | 2018-06-14 | — | — | US | disclosed |
| US-20180163101-A1 | CURABLE COMPOSITION, ESPECIALLY FOR RUBBER TO SUBSTRATE BONDING | HENKEL AG & CO. KGAA (DE) | 2018-06-14 | — | — | US | disclosed |
| US-9909039-B2 | Bonding compositions | Henkel IP Holding GmbH (DE) | 2018-03-06 | — | — | US | disclosed |
| US-9909039-B2 | Bonding compositions | Henkel IP Holding GmbH (DE) | 2018-03-06 | — | — | US | disclosed |
| US-9790348-B2 | Bonding composition comprising a sulfur impregnated particulate solid | HENKEL AG & CO. KGAA (DE) | 2017-10-17 | — | — | US | disclosed |
| US-20120202091-A1 | PHOSPHONATE BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-08-09 | — | — | US | disclosed |
| US-20120202091-A1 | PHOSPHONATE BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-08-09 | — | — | US | disclosed |
| US-20120193029-A1 | COMPOSITIONS FOR POLYMER BONDING | LOCTITE (R&D) LIMITED (IE) | 2012-08-02 | — | — | US | disclosed |
| US-20120193029-A1 | COMPOSITIONS FOR POLYMER BONDING | LOCTITE (R&D) LIMITED (IE) | 2012-08-02 | — | — | US | disclosed |
| US-20120164904-A1 | BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-06-28 | — | — | US | disclosed |
| US-20120164904-A1 | BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-06-28 | — | — | US | disclosed |
| WO-2011032998-A1 | PHOSPHONATE BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2011-03-24 | — | — | WO | disclosed |
| WO-2011029752-A1 | COMPOSITIONS FOR POLYMER BONDING | LOCTITE (R & D) LIMITED (IE) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011029751-A1 | BONDING COMPOSITIONS | LOCTITE (R & D) LIMITED (IE) | 2011-03-17 | — | — | WO | disclosed |
| WO-2009118255-A1 | POLYMER TO METAL BONDING AND COMPOUNDS AND COMPOSITIONS USEFUL THEREFOR | LOCTITE (R & D) LIMITED (IE) | 2009-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164904-A1 | BONDING COMPOSITIONS | AOX1, NOXO1, RIOX2 | HSP90AA1 2383/4885MAPK10 1921/4885MAPK8 3098/4885 |
| US-20120202091-A1 | PHOSPHONATE BONDING COMPOSITIONS | NOXO1, DDO, PTK2 | HSP90AA1 2922/4885MAPK10 329/4885MAPK8 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.